CellaVision AB (publ) (CLVSF) Investment Research Dashboard
About CellaVision AB (publ) (CLVSF) stock analysis
Get live CLVSF stock price $13.49, comprehensive CellaVision AB (publ) stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time CLVSF stock data and investment insights.
Loading chart data...
CellaVision AB (publ) (CLVSF) Overview
CellaVision AB (publ) (CLVSF) is a publicly traded company in the Healthcare sector , specifically within the Medical - Devices industry . As of the latest trading session, CLVSF trades at $13.49 with a market capitalization of 321.76M . Over the past 52 weeks, CLVSF has traded between $13.49 and $19.28 , with the current price positioned at approximately 0% of this range . The stock currently ...
Key Takeaways
- Operates in the Healthcare sector (Medical - Devices)
- Market cap: 321.76M
- Current price: $13.49
- 52-week range: $13.49 - $19.28
- P/E ratio: 22.54
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
CellaVision AB (publ), a company established in Lund, Sweden, in 1994, specializes in the development and distribution of digital analytical solutions for blood and body fluid samples. Their offerings cater to the healthcare services sector, with a s...
Company Information
- CEO
- Steve Ferguson
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 241
Contact Information
- Website
- https://www.cellavision.com
- Address
- Mobilvägen 12
- Country
- SE
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 22.5)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for CellaVision AB (publ) shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for CellaVision AB (publ)
- ⚠Investors should consider how CellaVision AB (publ) fits within their overall portfolio allocation
Market Cap
321.76M
P/E Ratio (TTM)
22.54
Beta
0.96
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
78/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +3.1% | +4.3% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +1.3% | +1.6% | 24.1 | 78/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | -0.7% | +2.9% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.8% | +0.7% | 29.7 | 64/100⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.2% | -0.2% | 25.2 | 61/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | +0.0% | -2.5% | 29.2 | 43/100⭐⭐⭐ |
| Energy | -2.1% | -3.7% | -4.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | +0.0% | -4.4% | 26.8 | 37/100⭐⭐ |
| Industrials | +0.6% | +0.4% | -9.9% | 30.1 | 23/100⭐ |
| Consumer Cyclical | +0.5% | -1.5% | -5.8% | 43.0 | 18/100⭐ |
| Technology | +0.6% | -1.6% | -7.2% | 40.7 | 15/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.